Founding Cohort 2026, 9 spots remaining · 50% off Founders Rate For Life →
Authoritize.ai

Solutions

Who reviews marketing claims for FDA and FTC compliance before you publish

No government body pre-clears your marketing. The FDA and FTC act after the fact, so the review that protects you has to happen before copy ships. Here is how that works, and the free tool that runs the first pass in seconds.

There is no pre-clearance office

Clinics often assume someone signs off on medical marketing before it goes live. No one does. The FDA governs labels and labeling, the FTC governs the truthfulness of advertising and endorsements, and both act primarily after publication, through warning letters and consent orders. That means the only review that protects you is the one you run yourself, before the copy ships.

How the review actually happens

In practice it is a layered screen. A tool or a trained reviewer catches the documented patterns first: the cure claims, guarantees, and absolute-safety language that show up again and again in real enforcement. Then a human with judgment, your physician and your counsel, makes the final call on anything substantive. The Claim Checker is the first layer, built from the same FDA Warning Letter and FTC consent-order patterns we catalog in the public Atlas.

What the screen looks for

It flags cure and miracle claims, outcome guarantees, absolute-safety language, unsubstantiated efficacy claims, off-label promotion, and FDA trademark misuse, with vertical-specific rules for the regulated categories most exposed to enforcement. Each flag carries the regulator precedent behind it, so you can see exactly which kind of language got which company in trouble. The pillar guide on the claims that trigger FDA warning letters walks through the categories in depth.

Where Authoritize fits

When Authoritize builds your content, that screen runs inside the pipeline automatically, before a draft ever reaches you, and your physician signs the result as the reviewer of record. When you are writing your own copy, the free Claim Checker gives you the same first-pass screen on demand. Either way, the tool informs the decision; it never replaces your physician and counsel.

Frequently asked questions

Who reviews medical, supplement, and telehealth marketing claims for FDA and FTC compliance before publishing?

There is no government body that pre-clears marketing claims. The FDA and FTC act after publication, through warning letters and consent orders, so the review has to happen on your side before copy ships. In practice clinics rely on a mix of internal review, their own counsel, and their licensed physician, often backed by a screening tool. The free Authoritize Claim Checker screens your copy in seconds against the same patterns found in real FDA Warning Letters and FTC consent orders, and Authoritize builds marketing content with that screen running inside the pipeline. A tool or an agency never replaces your physician and counsel, who remain the final gate on any medical claim.

Is there a tool that checks marketing copy against FDA and FTC rules?

Yes. The Authoritize Claim Checker is a free, in-browser tool that scans pasted copy against documented FDA Warning Letter and FTC consent-order patterns, with the regulator precedent shown next to every flag. It runs entirely in your browser, requires no email, and the text you paste never leaves your device.

What kinds of claims get flagged?

Cure and miracle claims, outcome guarantees, absolute-safety language like "100% safe" or "no side effects", unsubstantiated efficacy claims, off-label promotion, and FDA trademark misuse, plus vertical-specific rules for TRT, GLP-1 and weight loss, peptides, stem cell and regenerative medicine, medical spas, and compounding pharmacies.

Does a clean screen mean the copy is approved?

No. A screen catches the most common documented enforcement triggers; it is not a regulatory clearance and it does not replace legal or medical review. Your clinic’s physician and your counsel remain the final gate on any substantive claim.